Measuring patient health outcomes of primary health care reform using PROM (Patient Reported Outcome Measurement) instruments
The PROMs EKS Project Final Report is now available. Please click HERE to view the final report.
Patient Reported Outcome Measures (PROMs) are used to collect information from patients about their self-perceived health outcomes and quality of life that is not captured in other common outcome metrics (i.e., morbidity and mortality). This information is important for routine monitoring and ongoing evaluation of healthcare technologies and services.
The focus of this expedited knowledge synthesis project was on generic PROM instruments that measure a range of health outcomes relevant to a wide variety of clinical and population health contexts.
In collaboration with stakeholders (health researchers, clinicians and decision makers) we identified important instrument properties (psychometric and administrative) relevant to the integration of PROMs in primary care.
Our work considered 9 widely-cited generic PROM instruments and involved a review of existing reviews to aggregate information about the instruments' psychometric properties (e.g., ability to detect change, validity, reliability and generalizability).
The project adopted an integrated knowledge translation approach and concluded with an end-of-project workshop involving all of our project stakeholders. The full results of the project were presented and discussed with the purpose of identifying preferred instruments for implementation in BC. The workshop consensus was for further consideration of (a) the SF-36 and related instruments, (b) the Patient-Reported Outcomes Measurement Information System Global Health Scale (PROMIS-GHS) and (c) the EuroQol EQ-5D.
Regarding psychometric evidence reported in the reviews, the SF-36 (and its related instruments) was the strongest instrument in most of the properties considered. The PROMIS-GHS also performed well, but there is a smaller evidence base in part because its recent development. Evidence regarding cross-cultural validity was strongest for the EQ-5D.
All three instruments performed reasonably well in terms of patient burden (time for completion, word count and readability level) and coverage of important health outcome domains. The SF-36 instruments and EQ-5D are available in many languages.
C2E2 Rounds are presented Mondays from 12:00 pm to 1:00 pm in room 700 of the VGH Research Pavilion, 828 West 10th Avenue, Vancouver, BC.